Literature DB >> 15231160

[Epidemiologic surveillance for bacterial meningitis in 140 000 children under 5 years of age in Nanning district, Guangxi province].

Bai-qing Dong1, Zhen-zhu Tang, Mei Lin, Cui-yun Li, Dong-mei Tan, Da-bin Liang, He-zhuang Liao, Xian-zhi Liu, Yi Quan, Jin-song Fang, Xing-hua Wu, Wei-wen Qin, P E Kilgore, W A Kennedy, Zhi-yi Xu, J D Clemens.   

Abstract

OBJECTIVE: To characterize the incidence, epidemiologic features, etiologic agents and sequelae of bacterial meningitis in children under 5 years of age in Nanning, Guangxi.
METHODS: A population-based surveillance was conducted to evaluate children with signs and symptoms of meningitis. All hospitals, township health centers and village clinics in the surveillance area were structured to participate in the case referral and evaluation. Cerebrospinal fluid (CSF) and blood specimens were obtained and processed using standardized microbiologic methods.
RESULTS: During the 26-month surveillance period, among the children under 5 years old, a total of 1272 cases who met the screening criteria of meningitis were studied. 265 of 1272 cases were identified as clinically diagnosed meningitis, with an incidence rate of 86.36 per 100 000 population. The annual incidence rate under the 38 cases of confirmed bacterial meningitis appeared to be 12.38/100 000. Staphylococcus species accounted for the largest proportion of laboratory-confirmed bacterial meningitis, followed by E. coli and S. pneumoniae. The highest attack rate occurred in neonates < 1 month, followed by children aged 1 - 12 months in the confirmed patients. Meningitis caused by Sp and Hi mainly occurred in children aged 1 - 12 months. All cases of meningitis due to Hi and Sp were children aged 1 - 24 months. 13.16% and 0.00% of the cases survived with complications and sequelae, and the case-fatality rate was 18.42%. 40 bacterial isolates were identified from 1193 blood cultures and 23 from 1211 cerebrospinal fluid samples, but no Neisseria meningitidis was found.
CONCLUSION: Meningitis due to Hi was first confirmed in Guangxi with the incidence of 0.98 per 100 000 population. The annual incidence rate of confirmed bacterial meningitis was 12.38 per 100 000, which was considered an important public health problem in children. Staphylococci was the predominant pathogen in confirmed bacterial meningitis.

Entities:  

Mesh:

Year:  2004        PMID: 15231160

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  5 in total

1.  Evaluation of the BioFire FilmArray meningitis/encephalitis panel for the detection of bacteria and yeast in Chinese children.

Authors:  Bailu Du; Chunzhen Hua; Yijun Xia; Jin Li; Yongping Xie; Yue Tao; Qing Cao; Xi Mo
Journal:  Ann Transl Med       Date:  2019-09

Review 2.  Meningococcal disease in Asia: an under-recognized public health burden.

Authors:  A Vyse; J M Wolter; J Chen; T Ng; M Soriano-Gabarro
Journal:  Epidemiol Infect       Date:  2011-04-15       Impact factor: 2.451

3.  Bacterial Isolates from CSF Samples and Their Antimicrobial Resistance Patterns Among Children Under Five Suspected to Have Meningitis in Dilla University Referral Hospital.

Authors:  Ephrem Awulachew; Kuma Diriba; Netsanet Awoke
Journal:  Infect Drug Resist       Date:  2020-11-23       Impact factor: 4.003

4.  Population-based surveillance for bacterial meningitis in China, September 2006-December 2009.

Authors:  Yixing Li; Zundong Yin; Zhujun Shao; Manshi Li; Xiaofeng Liang; Hardeep S Sandhu; Stephen C Hadler; Junhong Li; Yinqi Sun; Jing Li; Wenjing Zou; Mei Lin; Shuyan Zuo; Leonard W Mayer; Ryan T Novak; Bingqing Zhu; Li Xu; Huiming Luo
Journal:  Emerg Infect Dis       Date:  2014-01       Impact factor: 6.883

5.  Development and validation of an advanced fragment analysis-based assay for the detection of 22 pathogens in the cerebrospinal fluid of patients with meningitis and encephalitis.

Authors:  Fang Long; Mimi Kong; Siying Wu; Weili Zhang; Quanfeng Liao; Zaisheng Peng; Li Nan; Ya Liu; Minjin Wang; Chao He; Yong Wu; Xiaojun Lu; Mei Kang
Journal:  J Clin Lab Anal       Date:  2019-01-21       Impact factor: 2.352

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.